Latest filing published 06 Sept 2023 for MiNK Therapeutics, Inc., €13k.
Insider track record
John Baldoni: trading record in brief
John Baldoni discloses dealings in MiNK Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 15 September 2022 to 1 September 2023, the count stands at 5 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 6 September 2023 with a share grant (€13k) in MiNK Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John Baldoni
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,846 shares@ US$1.4616.0% of flowCommon stockSEC:0000950170-23-046775:0
- 8,168 shares@ US$1.7616.1% of flowCommon stockSEC:0000899243-23-014409:0
- 6,878 shares@ US$2.0916.4% of flowCommon stockSEC:0000899243-23-006915:0
- 5,508 shares@ US$2.6116.7% of flowCommon stockSEC:0000899243-22-037655:0
- 10,974 shares@ US$2.6234.8% of flowCommon stockSEC:0000899243-22-031534:0
5 of 5 declarations